State Of Wisconsin Investment Board Eiger Bio Pharmaceuticals, Inc. Transaction History

State Of Wisconsin Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.99 - $8.96 $315,867 - $567,168	-63,300 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.84 - $9.74 $243,072 - $616,542	63,300 New	63,300 $525,000
Q2 2021 Aug 12, 2021	SELL	$7.82 - $9.23 $332,350 - $392,275	-42,500 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$7.98 - $12.29 $339,150 - $522,324	42,500 New	42,500 $522,000
Q1 2020 May 06, 2020	SELL	$4.91 - $14.7 $172,832 - $517,440	-35,200 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$9.59 - $12.0 $337,568 - $422,400	35,200 New	35,200 $361,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.